We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Tonix Pharmaceuticals

News List

Tonix Pharmaceuticals and Southern Research COVID-19 vaccine provides a novel vector expresspharma
June 28, 2020
As horsepox virus may have been accidentally extirpated there has most likely been no previous exposure to the vector, and any vaccine administered based on it is unlikely to encounter already-present neutralising antibodies.
Tonix and Southern Research to study immune responses to Covid-19 pharmaceutical-technology
June 19, 2020
Tonix Pharmaceuticals has expanded its ongoing partnership with non-profit Southern Research to study T-cell immune responses to SARS-CoV-2, the novel coronavirus that causes Covid-19.
Tonix Pharmaceuticals licences three Covid-19 vaccine candidates pharmaceutical-technology
May 11, 2020
Tonix Pharmaceuticals has signed a research collaboration and exclusive licensing agreement with the University of Alberta in Canada for three new vaccine candidates to prevent Covid-19.